[Hopespringpcsg] FW: CCSN Zytiga Survey, March 2013

[Glen Tolhurst]

Hi all:

See survey below.

Take care,

Glen Tolhurst

Chair- PCCN W-W 

 

From: Jackie Manthorne [mailto:jmanthorne=survivornet.ca at createsend1.com] On Behalf Of Jackie Manthorne



 




  <http://i5.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/spacer-top.jpg> 


Is this email not displaying correctly?

 <http://ccsn.createsend1.com/t/r-e-oqktjy-jjikahia-r/> View it in a web browser 

 <http://ccsn.forwardtomyfriend.com/r-jjikahia-8B18637E-oqktjy-l-y> Forward to a friend 

 


  <http://i7.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/line-break.jpg> 

 




  <http://i6.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/img1.jpg> 


CCSN March 18, 2013 E-alert


The Canadian Cancer Survivor Network (CCSN) is a national network of patients, families, survivors, friends, community partners, funders and sponsors who have come together to take action to promote the very best standards of care, whether it be early diagnosis, timely treatment and follow-up care, support for cancer patients, or issues related to survivorship or quality of end of life care.

 


  <http://i8.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/line-break-2.jpg> 

 




NEW! Canadian Cancer Survivor Network Survey on Zytiga


 

CCSN would like to thank you for filling out our recent survey on Xtandi, which helped us prepare our patient group submission to the pan-Canadian Oncology Drug Review. Thanks to your willingness to complete this survey, we had 30 completed surveys when the survey closed!

 

We are pleased to let you know that A SECOND SURVEY is now open for Zytiga (abiraterone acetate), another new medication for metastatic castration-resistant prostate cancer.

 

This medication has been available in Canada since 2011 for patients with metastatic castration-resistant prostate cancer in the post-chemotherapy stages. This national cancer drug review will consider its use in the pre-chemotherapy stage. The pan-Canadian Oncology Drug Review invites patient groups like CCSN to prepare and send in submissions so that patients and caregivers like you can be heard. Please join us and have your voice included in this important submission process.

 

The survey is available NOW and will remain open until April 5, 2013.


To access the survey, please go to https://www.surveymonkey.com/s/LN7K2BY

 


  <http://i7.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/line-break.jpg> 

 


  <http://i8.createsend1.com/ti/r/05/11E/5D2/035741/images/geometric/geometric/html/images/line-break-2.jpg> 

 


You are receiving this newsletter because you subscribed to our Newsletter.

Unsubscribe instantly. <http://ccsn.createsend1.com/t/r-u-oqktjy-jjikahia-j/> 

	

  <https://createsend1.com/t/r-o-oqktjy-jjikahia/o.gif> 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20130318/30090f46/attachment.html